BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Fish and Richardson
Farmers Insurance

Generated: November 20, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,018,992

« Back to Dashboard

Which drugs does patent 7,018,992 protect, and when does it expire?

Patent 7,018,992 protects VAGIFEM and is included in one NDA. There has been one Paragraph IV challenge on Vagifem.

This patent has eleven patent family members in ten countries.

Summary for Patent: 7,018,992

Title:Hormone composition
Abstract:Twice weekly administration of an analog to a Vagifem tablet which only contains 10 .mu.g of active material has a sufficient effect.
Inventor(s): Koch; Karen (Charlottenlund, DK), Kvorning; Ingelise (Bronshoj, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:10/016,858
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novo Nordisk Inc
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,018,992

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark2000 01891Dec 15, 2000
Denmark2000 01892Dec 15, 2000
Denmark2000 01890Dec 15, 2000

International Patent Family for Patent: 7,018,992

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Cyprus1112542► Subscribe
Germany20120246► Subscribe
Denmark1343508► Subscribe
European Patent Office1343508► Subscribe
European Patent Office2366395► Subscribe
Spain2376649► Subscribe
Japan2004515531► Subscribe
Japan4851057► Subscribe
Japan2010189409► Subscribe
Austria532521► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Fish and Richardson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus